NeoGenomics Inc. (NGNM) Announces First Quarter Results for 2011
NeoGenomics, Inc., an operator of cancer-focused testing laboratories in the US and Caribbean, recently released its first quarter results for the year 2011. Revenue for the first quarter of 2011 was $8.8 million, a 5% increase over the first quarter revenue of 2010, which was $8.4 million. Test volumes surged by approximately 10% over the comparable quarter of last year. Severe weather also had severe impacts on results for January and February, but volume increased steadily throughout the remaining half of the quarter. After adjusting for internalization of testing by one major client in 2010, revenue and test volume from…